European biotech
BMS backs record $600m European venture fund closed by LSP
Phil Taylor
European biotech, investment, Life Sciences, venture capital
0 Comment
Market Access/ News/ News/ R&D/ UK & Europe
Acacia Pharma stock market launch to support nausea products
Andrew McConaghie
Acacia Pharma, European biotech, UK biotech
0 Comment
Acacia Pharma is to raise new funds through an initial global offering and launch on to the Euronext Brussels stock exchange
News/ News/ R&D/ R&D/ UK & Europe
Sanofi steals in to buy Ablynx for €3.9 billion
Andrew McConaghie
Ablynx, European biotech, M&A, Mergers and acquisitions, Sanofi
0 Comment
News/ News/ R&D/ R&D/ UK & Europe
Google invests in UK vaccine pioneer Vaccitech
Andrew McConaghie
European biotech, Google, Google Ventures, UK biotech, Vaccitech
0 Comment
M&A/ News/ R&D/ UK & Europe
Takeda to buy stem cell specialists TiGenix for $626m
Richard Staines
European biotech, gastroenterology, M&A, Takeda, TiGenix
0 Comment
Decision follows EU regulators’ decision to back Crohn’s stem cell therapy
Boehringer collaborates with Autifony on schizophrenia drug
Richard Staines
Autifony, Boehringer Ingelheim, European biotech, R&D, schizophrenia, UK biotech
0 Comment
Deal could be worth 627.5 million euros
Gilead could make a move for Galapagos within weeks
Andrew McConaghie
European biotech, Galapagos, Gilead
0 Comment
News/ R&D/ Top stories/ US
After more encouraging data, Ablynx to file first drug with FDA
Richard Staines
Ablynx, aTTP, Biotech, European biotech, Rare diseases
0 Comment
New trial data will be included in US and EU filings